Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion

Summary

Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.